CEA-EDF-INRIA General information

More information:

• Program and slides
• Teaching Materials
• General Information
• Other relevant information from the BANG INRIA project-team
• Sponsors
• Registration form

Scientific Organisers:
Jean Clairambault	INRIA Paris - Rocquencourt
Dirk Drasdo	INRIA Paris - Rocquencourt

Speakers:
Andrea Ciliberto	IFOM-IEO Campus, Milan, Italy
Franck Delaunay	Université de Nice-Sophia Antipolis, Nice
David Dingli	Mayo Clinic, Rochester, MN, USA
Charles Dumontet	Université Lyon 1, Lyon
Albert Goldbeter	Université libre de Bruxelles, Bruxelles, Belgium
Sriram Krishnamachari	INRIA Paris-Rocquencourt
Francis Lévi	Hôpital Paul Brousse, Villejuif
Markus Löffler	University of Leipzig, Leipzig, Germany
Stephan Luckhaus	University of Leipzig, Leipzig, Germany
Michael Mackey	McGill University, Montréal, Canada
Benoît Perthame	INRIA Paris - Rocquencourt
Luigi Preziosi	University of Turin, Turin, Italy
Olivier Saut	Université de Bordeaux 1, Bordeaux
Bertrand Tavitian	CEA Saclay, Saclay
Stephen Randall Thomas	Université d’Evry, Evry
Paolo Ubezio	Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy

Presentation:

Cancer is a multiscale systems disease that transforms a tissue, homogeneous and sensitive to physiological variables controlling proliferation and differentiation, into a heterogeneous, but robust, ensemble of cells able to evade these controls, proliferate and survive radio-or chemotherapy insults by various adaptive ways.

Mathematical methods and their numerical implementations are currently being used in different theoretical settings by various teams of scientists to accurately represent the physiological bases of cell proliferation and its control, normal or disrupted, at the single cell and cell population levels.

The points of view that will be presented in this school range, from normal and pathological cell proliferation representation by physiological (molecular- or mechanistic-based) and phenomenological (descriptive) models, to the evolutionary dynamics of cancer and to problems encountered by oncologists when attempting to define new ways to improve the therapeutic methods that are currently used in the clinic.

Objective:

The school is intended for PhD students, scientists and company engineers who are interested in working with the help of mathematical modelling methods in the field of cancer.

Sponsors

		GDR MABEM (Modélisation mathématique en biologie et médecine)
MITACS Network of Canada	M3CSTGT Network of European Union FP6	GDR MABEM of CNRS